Current Report Filing (8-k)
20 2월 2020 - 1:10AM
Edgar (US Regulatory)
falseNJ0000091928--12-3100000919282020-02-182020-02-180000091928us-gaap:CommonStockMember2020-02-182020-02-180000091928sji:CorporateUnitsMember2020-02-182020-02-180000091928sji:Five625JuniorSubordinatedNotesDue2079Member2020-02-182020-02-18
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): February 18, 2020
SOUTH JERSEY INDUSTRIES, INC.
(Exact Name of Registrant as Specified in Charter)
1 South Jersey Plaza, Folsom, NJ 08037
(Address of Principal Executive Offices) (Zip Code)
(609) 561-9000
(Registrant's Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
Securities registered pursuant to Section 12(b) of the Act:
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this
chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
On February 14, 2020, the Board of Directors (the “Board) of South Jersey Industries, Inc. (the Company”), upon the recommendation of the Governance
Committee, elected Mr. Kevin O’Dowd, Co-President and CEO of Cooper University Healthcare,, as a new director effective as of February 14, 2020, (“the Effective Date”). The Company expects that Mr. O’Dowd will be appointed to committees by the Board following the Company’s annual meeting of shareholders in the second quarter of 2020.
Mr. Holland does not have any familial relationship with an director or executive officer of the Company and there are no transactions that require disclosure pursuant to
Item404(a) of Regulation S-K.
Mr. Holland will participate in the Company’s nonemployee director compensation programs, which are described in the Company’s proxy statement for its 2019 Annual Meeting
of Shareholders filed with the Securities and Exchange Commission on March 15, 2019.
A copy of the Company’s press release announcing the election of Mr. Holland is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
In connection with the election of Mr. Holland, the Board approved an amendment to the Company’s By-Laws increasing the number of Board Members from ten
(11) to eleven (12). The revised applicable provision of the By-Laws is attached hereto as Exhibit 3.1.
Item 9.01(d) Exhibits.
Exhibit Index
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
South Jersey Industries (NYSE:SJIU)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
South Jersey Industries (NYSE:SJIU)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
South Jersey Industries Inc (뉴욕 증권거래소)의 실시간 뉴스: 최근 기사 0
More South Jersey Industries Inc News Articles